Found 23 matching trials
A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS) PHASE2 This study will evaluate a new immunosupressive therapy, Daclizumab, and co...
Show More Location
National Heart, Lung and Blood Institute (NHLBI)
Learn More & Join Trial
Anti-Tac for Treatment of Leukemia PHASE1 The purpose of the study was to determine: (1) the toxicity and maximum tol...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
REGN7257 in Adult Patients With Severe Aplastic Anemia That Is Refractory to or Relapsed on Immunosuppressive Therapy PHASE1 This study is researching an experimental drug called REGN7257 (called "stu...
Show More Location
Cleveland Clinic Foundation
Learn More & Join Trial
CNI-free de Novo Protocol in Patients Undergoing Liver Transplantation With Renal Impairment PHASE3 Background:
Patients undergoing liver transplantation with preexisting ren...
Show More Location
Regensburg University Medical Center, Department of Surgery
Learn More & Join Trial
Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac PHASE1 The study purpose is to evaluate the clinical response to multidose adminis...
Show More Location
National Cancer Institute (NCI)
Learn More & Join Trial
Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation. PHASE3 To compare the efficacy and safety of two regimens containing tacrolimus an...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy Study of Thymoglobulin Versus IL2 Receptor Antagonists NA The purpose of this study is to evaluate the safety and efficacy of inducti...
Show More Location
Medical University of South Carolina
Learn More & Join Trial
Sequential Therapy (FK506 + Monoclonal Anti-IL2R Antibodies + MMF) Versus FK506 With Steroids in Liver TX PHASE2 Study to evaluate the benefits and any risks of the delayed administration ...
Show More Location
Multiple Locations
Learn More & Join Trial
Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS PHASE2 This study will evaluate the safety and effectiveness of stem cell transpla...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak) PHASE2 This study examines the use of denileukin diftitox (Ontak) for patients wit...
Show More Location
Washington University
Learn More & Join Trial